N-(3,4-Dihydro-4-oxo-2H-1-benzothiopyran-6-yl)acetamide | CAS:103989-04-4
            
            N-(3,4-Dihydro-4-oxo-2H-1-benzothiopyran-6-yl)acetamide
            - Name:N-(3,4-Dihydro-4-oxo-2H-1-benzothiopyran-6-yl)acetamide
 - CAS:103989-04-4
 - Synonyms:
 - Molecular Formula:C11H11NO2S
 - Molecular Weight:221.28
 - EINESC:
 
Description
Properties
| Density | 1.338 | 
|---|
Safety
| 没有数据 | 没有数据 | 
|---|
SDS
| Source | SDS/MSDS Samples | 
|---|---|
| 没有数据 | 没有数据 | 
Synthetic Route
                | Name | CAS | 
|---|
More
            Articles
                Peer-Reviewed Papers
                
                                        Effect of decursin on the pharmacokinetics of theophylline and its metabolites in rats.Jung-woo Chae et al.Journal of ethnopharmacology, 144(2), 248-254 (2012-09-18)
                                        A novel derivative of decursin, CSL-32, blocks migration and production of inflammatory mediators and modulates PI3K and NF-κB activities in HT1080 cells.Seung-Hee Lee et al.Cell biology international, 36(7), 683-688 (2012-06-12)
                                        First-pass metabolism of decursin, a bioactive compound of Angelica gigas, in rats.Hyun Seo Park et al.Planta medica, 78(9), 909-913 (2012-05-11)
                                        Decursin chemosensitizes human multiple myeloma cells through inhibition of STAT3 signaling pathway.Hyun Jung Kim et al.Cancer letters, 301(1), 29-37 (2010-12-03)
                                        Ultrafine Angelica gigas powder normalizes ovarian hormone levels and has antiosteoporosis properties in ovariectomized rats: particle size effect.Kyeong-Ok Choi et al.Journal of medicinal food, 15(10), 863-872 (2012-10-09)
                                        Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.Li Li et al.Planta medica, 78(3), 252-259 (2011-11-26)
                                        Overexpression of cinnamate 4-hydroxylase gene enhances biosynthesis of decursinol angelate in Angelica gigas hairy roots.Nam Il Park et al.Molecular biotechnology, 50(2), 114-120 (2011-06-01)
                                        Pharmacokinetic characterization of decursinol derived from Angelica gigas Nakai in rats.Jin Sook Song et al.Xenobiotica; the fate of foreign compounds in biological systems, 41(10), 895-902 (2011-06-11)
                                        A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.Yong Zhang et al.Investigational new drugs, 30(5), 1820-1829 (2011-08-27)
                                        A (S)-(+)-decursin derivative, (S)-(+)-3-(3,4-dihydroxy-phenyl)-acrylic acid 2,2-dimethyl-8-oxo-3,4-dihydro-2H,8H-pyrano[3,2-g]-chromen-3-yl-ester, attenuates the development of atopic dermatitis-like lesions in NC/Nga mice.In Sik Kim et al.Molecular biology reports, 40(3), 2541-2548 (2013-01-08)
                                        Decursin attenuates hepatic fibrogenesis through interrupting TGF-beta-mediated NAD(P)H oxidase activation and Smad signaling in vivo and in vitro.Young Ji Choi et al.Life sciences, 108(2), 94-103 (2014-06-01)
                                        Synthesis of (S)-(+)-decursin and its analogues as potent inhibitors of melanin formation in B16 murine melanoma cells.Kyeong Lee et al.European journal of medicinal chemistry, 45(12), 5567-5575 (2010-10-05)
                                        Chemometric classification of morphologically similar Umbelliferae medicinal herbs by DART-TOF-MS fingerprint.Sang Min Lee et al.Phytochemical analysis : PCA, 23(5), 508-512 (2012-01-25)
                                        Decursin from Angelicagigas Nakai induces apoptosis in RC-58T/h/SA#4 primary human prostate cancer cells via a mitochondria-related caspase pathway.Sa-Ra Choi et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 49(10), 2517-2523 (2011-06-23)
                                        Biopharmaceutical characterization of decursin and their derivatives for drug discovery.Bimit Mahat et al.Drug development and industrial pharmacy, 39(10), 1523-1530 (2012-09-26)
                                        Decursin, an active compound isolated from Angelica gigas, inhibits fat accumulation, reduces adipocytokine secretion and improves glucose tolerance in mice fed a high-fat diet.Jin-Taek Hwang et al.Phytotherapy research : PTR, 26(5), 633-638 (2011-10-06)
                                        Decursin exerts anti-cancer activity in MDA-MB-231 breast cancer cells via inhibition of the Pin1 activity and enhancement of the Pin1/p53 association.Ji-Hyun Kim et al.Phytotherapy research : PTR, 28(2), 238-244 (2013-04-13)
                                        Effect of decursinol angelate on the pharmacokinetics of theophylline and its metabolites in rats.Jung-woo Chae et al.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association, 50(10), 3666-3672 (2012-07-10)
                                        Inhibition of angiogenic attributes by decursin in endothelial cells and ex vivo rat aortic ring angiogenesis model.Tariq A Bhat et al.Indian journal of experimental biology, 49(11), 848-856 (2011-12-01)
                                        Decursin and decursinol from Angelica gigas inhibit the lung metastasis of murine colon carcinoma.Seung Hwa Son et al.Phytotherapy research : PTR, 25(7), 959-964 (2010-12-21)
                                        Decursin inhibits vasculogenesis in early tumor progression by suppression of endothelial progenitor cell differentiation and function.Seok Yun Jung et al.Journal of cellular biochemistry, 113(5), 1478-1487 (2012-02-03)
                                        Single oral dose pharmacokinetics of decursin, decursinol angelate, and decursinol in rats.Li Li et al.Planta medica, 79(3-4), 275-280 (2013-02-01)
                                    
            Remarks
                
            Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
| Name | CAS | 
|---|
        
Related Products
Related News
Question
    Hot Tags
    Inquiry
Fill in related informations ;please!
- Please fill in product name !
 - CAS
 - Please fill in your company information correctly!
 - Please fill in liaison information correctly!
 - Please fill in your telephone number correctly!
 - Please fill in your email correctly!
 - Please describe the problem of products!